Distal deletion 13q syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1590OMIM:602553Q93.5
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Distal deletion 13q syndrome (also known as distal monosomy 13q or 13q deletion syndrome, distal type) is a rare chromosomal disorder caused by a partial deletion of the long arm (q arm) of chromosome 13, specifically involving the distal (far end) region. The size and exact location of the deleted segment can vary among affected individuals, which leads to a wide spectrum of clinical severity. This condition is typically identified at birth or during early childhood based on characteristic clinical features. The syndrome affects multiple body systems. Key clinical features include intellectual disability of variable severity, growth retardation, craniofacial dysmorphisms (such as microcephaly, a broad nasal bridge, a short nose, micrognathia, and low-set ears), and limb anomalies. Notably, deletions involving the 13q32 region are frequently associated with more severe manifestations, including holoprosencephaly (a brain malformation where the forebrain fails to divide properly), eye abnormalities (microphthalmia, coloboma, or anophthalmia), and genital anomalies in males (hypospadias, cryptorchidism). Congenital heart defects and gastrointestinal malformations such as Hirschsprung disease may also occur. Distal 13q deletions that include the retinoblastoma gene (RB1) locus at 13q14 may predispose to retinoblastoma, though this is more characteristic of proximal deletions. There is no cure for distal deletion 13q syndrome. Management is supportive and multidisciplinary, tailored to the individual's specific clinical manifestations. This may include surgical correction of congenital anomalies (cardiac, gastrointestinal, or craniofacial), early intervention programs, speech and occupational therapy, and regular ophthalmologic and developmental assessments. Genetic counseling is recommended for affected families to assess recurrence risk, as most cases arise de novo, though parental chromosomal rearrangements (such as balanced translocations) can increase the risk of recurrence.

Also known as:

Clinical phenotype terms— hover any for plain English:

AnencephalyHP:0002323Aplasia/Hypoplasia affecting the eyeHP:0008056Primary adrenal insufficiencyHP:0008207
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Distal deletion 13q syndrome.

View clinical trials →

No actively recruiting trials found for Distal deletion 13q syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Distal deletion 13q syndrome community →

No specialists are currently listed for Distal deletion 13q syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Distal deletion 13q syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Distal deletion 13q syndromeForum →

No community posts yet. Be the first to share your experience with Distal deletion 13q syndrome.

Start the conversation →

Latest news about Distal deletion 13q syndrome

No recent news articles for Distal deletion 13q syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Distal deletion 13q syndrome

What is Distal deletion 13q syndrome?

Distal deletion 13q syndrome (also known as distal monosomy 13q or 13q deletion syndrome, distal type) is a rare chromosomal disorder caused by a partial deletion of the long arm (q arm) of chromosome 13, specifically involving the distal (far end) region. The size and exact location of the deleted segment can vary among affected individuals, which leads to a wide spectrum of clinical severity. This condition is typically identified at birth or during early childhood based on characteristic clinical features. The syndrome affects multiple body systems. Key clinical features include intellectu

At what age does Distal deletion 13q syndrome typically begin?

Typical onset of Distal deletion 13q syndrome is neonatal. Age of onset can vary across affected individuals.